Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalyzed Asymmetric Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103288829A details an iridium-catalyzed asymmetric hydrogenation route for chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepino-5-one, offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN108101785A reveals iridium catalysis for chiral beta-hydroxy esters. Offers high ee and mild conditions for pharma supply chains. Enables cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106995413A reveals high-ee iridium-catalyzed hydrogenation for chiral piperazines, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.